HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhisa Fujii Selected Research

Nivolumab

1/2021Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab.
1/2020Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhisa Fujii Research Topics

Disease

89Neoplasms (Cancer)
04/2024 - 07/2003
52Prostatic Neoplasms (Prostate Cancer)
03/2024 - 06/2004
43Urinary Bladder Neoplasms (Bladder Cancer)
11/2023 - 08/2003
40Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 10/2002
34Neoplasm Metastasis (Metastasis)
07/2023 - 08/2003
25Carcinoma (Carcinomatosis)
01/2021 - 10/2003
12Lymphatic Metastasis
07/2023 - 07/2003
11Type 2 Diabetes Mellitus (MODY)
01/2009 - 03/2002
9Insulin Resistance
01/2009 - 03/2002
8Adenoma (Adenomas)
12/2023 - 10/2003
8Kidney Neoplasms (Kidney Cancer)
01/2023 - 08/2012
5Disease Progression
01/2022 - 08/2008
5Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2021 - 12/2007
5Hypertension (High Blood Pressure)
10/2020 - 09/2003
4Carcinogenesis
12/2023 - 10/2003
4Inguinal Hernia (Direct Inguinal Hernia)
06/2023 - 03/2010
4Infections
12/2022 - 01/2009
4Non-Muscle Invasive Bladder Neoplasms
01/2021 - 01/2020
3Lower Urinary Tract Symptoms
11/2023 - 12/2013
3Obesity
01/2023 - 09/2003
3False Aneurysm (Pseudoaneurysm)
01/2021 - 12/2015
3Hyperaldosteronism (Conn Syndrome)
05/2020 - 12/2015
3Fibrosis (Cirrhosis)
01/2020 - 06/2007
3Inflammation (Inflammations)
01/2016 - 06/2002
3Diabetes Mellitus
09/2012 - 12/2009
3Hypoxia (Hypoxemia)
10/2006 - 01/2006
2Chronic Kidney Failure (Chronic Renal Failure)
10/2023 - 03/2016
2Pathologic Complete Response
09/2023 - 02/2010
2Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2023 - 03/2022
2Adrenocortical Carcinoma
04/2023 - 08/2003
2Frailty
01/2023 - 03/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023 - 07/2008
2Cushing Syndrome
01/2022 - 05/2020
2Adrenocortical Adenoma (Disease, Conn's)
01/2022 - 07/2019
2Hyperplasia
01/2022 - 10/2012
2Spinal Cord Injuries (Spinal Cord Injury)
12/2021 - 01/2018
2Hernia (Hernias)
01/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

23Cisplatin (Platino)FDA LinkGeneric
11/2023 - 08/2003
15C-Reactive ProteinIBA
04/2024 - 08/2007
15Prostate-Specific Antigen (Semenogelase)IBA
01/2023 - 06/2004
13Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2011
8ResistinIBA
01/2009 - 03/2002
7AldosteroneIBA
12/2023 - 08/2015
7Hormones (Hormone)IBA
01/2023 - 05/2006
7pembrolizumabIBA
08/2022 - 01/2020
7Etoposide (VP 16)FDA LinkGeneric
01/2021 - 08/2003
7Insulin (Novolin)FDA Link
01/2019 - 03/2002
7AndrogensIBA
08/2015 - 05/2006
5Immune Checkpoint InhibitorsIBA
03/2021 - 01/2020
5Zoledronic Acid (Zometa)FDA Link
12/2016 - 06/2008
4Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022 - 05/2006
4CytokinesIBA
12/2021 - 11/2007
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2021 - 02/2004
4IfosfamideFDA LinkGeneric
01/2021 - 09/2008
4Diphosphonates (Bisphosphonates)IBA
10/2013 - 06/2008
4CollagenIBA
12/2009 - 06/2007
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2006 - 10/2004
3Capsules (Microcapsules)IBA
03/2024 - 08/2017
3RNA (Ribonucleic Acid)IBA
12/2023 - 01/2012
3AntigensIBA
12/2023 - 07/2003
3Docetaxel (Taxotere)FDA Link
07/2023 - 10/2012
3Therapeutic UsesIBA
03/2023 - 10/2006
3Testosterone (Sustanon)FDA Link
01/2023 - 05/2008
3Androgen Receptors (Androgen Receptor)IBA
01/2022 - 06/2004
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
04/2020 - 05/2008
3Sunitinib (Sutent)FDA Link
01/2020 - 01/2015
3Indicators and Reagents (Reagents)IBA
07/2019 - 06/2006
3Cytochrome P-450 CYP11B2 (CYP11B2)IBA
07/2019 - 08/2015
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 07/2008
3DNA (Deoxyribonucleic Acid)IBA
01/2019 - 08/2015
3Adenosine Monophosphate (AMP)IBA
07/2013 - 01/2009
3Proteins (Proteins, Gene)FDA Link
01/2012 - 10/2003
3GlucocorticoidsIBA
10/2006 - 10/2004
2AcidsIBA
11/2023 - 01/2019
2enzalutamideIBA
07/2023 - 01/2018
2durvalumabIBA
06/2023 - 03/2022
2CreatinineIBA
04/2021 - 03/2008
2Tyrosine Kinase InhibitorsIBA
01/2021 - 12/2017
2NivolumabIBA
01/2021 - 01/2020

Therapy/Procedure

47Therapeutics
07/2023 - 08/2003
30Nephrectomy
10/2023 - 10/2002
28Cystectomy
11/2023 - 10/2003
21Prostatectomy (Retropubic Prostatectomy)
01/2023 - 11/2007
19Drug Therapy (Chemotherapy)
11/2023 - 08/2003
18Chemoradiotherapy
05/2023 - 10/2003
17Castration
07/2023 - 05/2008
15Radiotherapy
11/2023 - 11/2007
9Lymph Node Excision (Lymph Node Dissection)
11/2022 - 11/2004
8Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 09/2008
6Adrenalectomy
05/2020 - 09/2003
5Nephroureterectomy
01/2019 - 06/2006
5Urinary Diversion (Ileal Conduit)
06/2014 - 12/2003
4Combined Modality Therapy
09/2023 - 08/2003
3Transurethral Resection of Bladder
11/2023 - 03/2006
3Artificial Urinary Sphincter
11/2023 - 09/2020
3Neoadjuvant Therapy
11/2023 - 11/2007
3Endoscopes
06/2023 - 05/2002
3Intravesical Administration
12/2022 - 08/2003
3Brachytherapy
01/2022 - 07/2021
2Heavy Ion Radiotherapy
06/2023 - 03/2022